Sunday, 4 October 2026European Markets

AKER BP And AKER SOLUTIONS Have A High Dividend Yield And Return On Equity In The Energy Sector.

Loading stream...

(VIANEWS) - AKER BP (AKRBP.OL) is among this list of stock assets with the highest dividend rate and return on equity on the Energy sector.

Financial Asset Price Forward Dividend Yield Return on Equity
AKER BP (AKRBP.OL) kr257.90 7.87% 11.97%
AKER SOLUTIONS (AKSO.OL) kr35.06 2.01% 17.09%

Several Euronext companies pay out dividends to its shareholders. The dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. AKER BP (AKRBP.OL)

7.87% Forward Dividend Yield and 11.97% Return On Equity

Aker BP ASA explores for, develops, and produces oil and gas on the Norwegian Continental Shelf. The company was formerly known as Det norske oljeselskap ASA and changed its name to Aker BP ASA in October 2016. Aker BP ASA was founded in 2001 and is headquartered in Fornebu, Norway.

Earnings Per Share

As for profitability, AKER BP has a trailing twelve months EPS of kr18.8.

PE Ratio

AKER BP has a trailing twelve months price to earnings ratio of 13.72. Meaning, the purchaser of the share is investing kr13.72 for every norwegian krone of annual earnings.

Return on Equity

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 11.97%.

More news about AKER BP.

2. AKER SOLUTIONS (AKSO.OL)

2.01% Forward Dividend Yield and 17.09% Return On Equity

Aker Solutions ASA provides solutions, products, systems, and services to the oil and gas industry worldwide. It offers field planning, feasibility, and concept studies; specialist engineering, project management, and procurement services; floater designs, offshore wind, as well as engages in design, delivery, and construction of deep-water risers, oil, and gas production, and receiving and processing facilities. In addition, the company provides offshore fish farming, carbon capture, utilization and storage, hydrogen, and offshore wind solutions. Further, the company designs and constructs jackets for construction services and offers electrification services; and designs and constructs offshore oil and gas production facilities and onshore receiving and processing facilities. Additionally, the company provides subsea production, compression, pump, power distribution, and processing systems, and subsea lifecycle services. Furthermore, the company offers maintenance, modifications, decommissioning, asset integrity management, hook-up, and completion solutions. Aker Solutions ASA was founded in 1841 and is headquartered in Fornebu, Norway.

Earnings Per Share

As for profitability, AKER SOLUTIONS has a trailing twelve months EPS of kr3.41.

PE Ratio

AKER SOLUTIONS has a trailing twelve months price to earnings ratio of 10.28. Meaning, the purchaser of the share is investing kr10.28 for every norwegian krone of annual earnings.

Return on Equity

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 17.09%.

Growth Estimates Quarters

The company's growth estimates for the ongoing quarter and the next is 100% and 16.5%, respectively.

Yearly Top and Bottom Value

AKER SOLUTIONS's stock is valued at kr35.06 at 11:30 EST, way below its 52-week high of kr50.00 and higher than its 52-week low of kr33.14.

More news about AKER SOLUTIONS.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Pharma Pipeline Catalysts and M&A Heat Up as AI-Designed Drugs Enter the Clinic
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Apple Inc.
The observation date (2025-12-27) precedes Q1 2026, making it logically impossible to have actual Q1 2026 cash data at that point. Q1 2026 would not end until March 31, 2026. Additionally, the magnitude of the difference ($45.3B vs $132.42) is implausibly large even as a normal quarterly change for Apple. While different fiscal periods can show different values, the timing relationship here suggests a data integrity issue rather than legitimate period-over-period variation.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,329 source documents archived
Query this data → isubstrate.com